RecruitingTricuspid Regurgitation
TriClip CED RWE Study
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.
Sponsor: Abbott Medical Devices
You may qualify if…
- ✓ Patients ≥ 18 years of age at time of implant
- ✓ Patients with symptomatic, severe or greater Tricuspid Regurgitation who have received the TriClip system (treatment group) or have not undergone T-TEER (control group)
You may not qualify if…
- ✕ Patients with less than severe Tricuspid Regurgitation
- ✕ Patients with a prior history of surgical or transcatheter tricuspid valve replacement
- ✕ Patients with a surgical or transcatheter aortic or mitral valve intervention within 90 days prior to index
Where it's recruiting
California
Santa Clara
Source: ClinicalTrials.gov · NCT06920745 · last updated 2025-08-11